GlobeNewsWire
27 Jun 2026, 14:10 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
A securities fraud class action lawsuit has been filed against ADMA Biologics alleging the company used 'channel stuffing' to artificially inflate revenue growth. — Allegations of fraudulent revenue reporting and channel stuffing directly undermine the company's financial integrity and reported growth rates.
-0.80Culper Research reported that ADMA Biologics allegedly induced distributors to stock excess ASCENIV via rebates and extended payment terms to meet order expectations. — This provides a specific mechanism for the alleged fraud, suggesting that reported 20% growth may actually be -3% real growth.
-0.70The lawsuit alleges ADMA Biologics engaged in an undisclosed related party transaction and lacked adequate internal controls. — Poor internal controls and undisclosed related party transactions are red flags for governance failures and further financial irregularities.
-0.50Continue reading
6 related stories
Top 2 movers · tap to explore
ADMA Biologics' stock price fell 29.1% over two trading days following the publication of the Culper Research report. — This confirms immediate negative market reaction and established downward price momentum based on these allegations.
-0.30Which stocks this story touches
The company is the subject of a securities fraud class action lawsuit investigation.
The company is facing a securities fraud class action lawsuit following allegations of channel stuffing and undisclosed related party transactions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
7h ago
